Search
Now showing items 1-10 of 11
Prospective controlled study of post-transfusion hepatitis after cardiac surgery in a large referral hospital in India.Live
(1992)
We studied the risk of post-transfusion hepatitis (PTH) in recipients of blood collected from voluntary donors screened for HBsAg. Two hundred and fifty patients without any previous history of liver disease or transfusion ...
A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure
(1993)
The efficacy of the interferon stimulator named Stronger Neo Minophagen-C (SNMC) derived form the plant G. glabra was studied at a dose of 40 or 100 ml daily for 30 days followed by thrice weekly intravenously for 8 wk in ...
Role of fibronectin and complement in immunopathogenesis of acute and subacute hepatic failure.
(1994)
The present study describes the plasma levels of soluble fibronectin (FN), C3d, the breakdown product of C3 complement and Ba, the breakdown product of properdin factor B, in 30 patients of uncomplicated acute viral hepatitis ...
Hospital malnutrition: a prospective evaluation of patients during hospitalisation
(1991)
Nutritional Status of 89 patients was assessed during their course of hospitalisation. All patients consumed diet deficit in protein and calories. The mean daily intake of calories was 819 +/- 425 Kcals and of protein was ...
Significance of anti-pre-S antibodies in patients with fulminant hepatic failure
(1990)
Anti-pre-S antibody was tested in 38 sera from patients with fulminant hepatitis (positive for HBsAg and/or IgM anti-HBc) using a specific solid phase enzyme linked immunosorbent assay (ELISA). Anti-pre-S activity was ...
Hepatitis B virus replication in patients with chronic liver diseases
(1990)
One hundred and seventy five subjects with chronic liver diseases which included patients with chronic active hepatitis (90), liver cirrhosis (31) and asymptomatic hepatitis B carriers (54), were included in the study. ...
Hepatitis C virus infection is the major cause of severe liver disease in India
(1991)
The present study describes the status of hepatitis C virus infection in 167 patients with severe forms of liver diseases in India. The anti-HCV positivity rate was recorded as 43%, 47%, and 42% in patients with FHF, SAHF, ...
Prevalence of hepatitis C virus antibodies in the general population & in selected groups of patients in Delhi
(1995)
We report on the prevalence of anti-HCV antibodies in healthy individuals and patient groups with different liver diseases. The healthy population comprising 234 voluntary blood donors and 65 pregnant women with no history ...